Completed enrollment in 4D-150 4FRONT-1 wet AMD Phase 3 trial within approximately 11 months, ahead of initial projections and reflecting strong ...
52m
CytoNiche’s 3D FloTrix™ Platform Wins ‘Emerging Bioprocessing Supplier Award’ at ABEA 2026
CytoNiche’s 3D FloTrix™ platform won the Emerging Bioprocessing Supplier – Downstream award at ABEA 2026, recognising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results